Business · 10/01/2007
FDA Publishes Guidance for Quality Control Material of Cystic Fibrosis Nucleic Acid Assays
The Food and Drug Administration (FDA) has released a guidance document outlining the requirements for quality control material in cystic fibrosis nucleic acid assays, which will be implemented immediately as a special control for these devices.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →